Q1 2026 saw $3.74B in longevity biotech investment, 173 AI-discovered drugs in trials, and the first FDA-approved mitochondrial therapy. The sector's bottleneck is no longer discovery; it's delivery.
Data from 340+ events compared: speakers, topics, formats, and sponsorship across European and American longevity conferences. Find the right circuit for your goals.
A data-driven overview of the 340+ longevity conferences tracked across 42 countries in 2026 — formats, top cities, seasonal patterns, and how to choose the right event.
Stem cells, senolytics, epigenetic reprogramming — where the field is meeting in 2026. A breakdown of the regenerative medicine conference circuit for organisers, speakers, and investors.
First time attending a longevity summit? Here's what the data shows about session formats, speaker profiles, hot topics, and how to get the most out of any longevity conference.